3-hydroxypregn-4-en-20-one has been researched along with halothane in 1 studies
Studies (3-hydroxypregn-4-en-20-one) | Trials (3-hydroxypregn-4-en-20-one) | Recent Studies (post-2010) (3-hydroxypregn-4-en-20-one) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
---|---|---|---|---|---|
29 | 0 | 2 | 14,369 | 884 | 235 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LL; Harris, RA; Lin, LH; Zirrolli, JA | 1 |
1 other study(ies) available for 3-hydroxypregn-4-en-20-one and halothane
Article | Year |
---|---|
General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium.
Topics: 20-alpha-Dihydroprogesterone; Anesthetics; Animals; Binding Sites; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; Enflurane; Female; gamma-Aminobutyric Acid; Halothane; Male; Mice; Mice, Inbred BALB C; Oocytes; Receptors, GABA-A; Xenopus | 1992 |